 |
(9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of post-operative complications of aortic anuerysm surgical repair |
| USA Market Approval | USA |
| USA Designation Date | 2004-12-08 00:00:00 |
| Sponsor | Inotek Pharmaceuticals Corporation;100 Cummings Center;Beverly, Massachusetts, 01915 |
